226 related articles for article (PubMed ID: 23551241)
1. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
[TBL] [Abstract][Full Text] [Related]
3. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.
Wang Q; Zhou JQ; Zhou LM; Chen ZY; Fang ZY; Chen SD; Yang LB; Cai XD; Dai QL; Hong H; Wang HX
Seizure; 2011 Jul; 20(6):446-8. PubMed ID: 21397523
[TBL] [Abstract][Full Text] [Related]
4. Severe cutaneous adverse reactions to antiepileptic drugs in Asians.
Yang CY; Dao RL; Lee TJ; Lu CW; Yang CH; Hung SI; Chung WH
Neurology; 2011 Dec; 77(23):2025-33. PubMed ID: 22116946
[TBL] [Abstract][Full Text] [Related]
5. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
6. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
7. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
Wu XT; Hu FY; An DM; Yan B; Jiang X; Kwan P; Stefan H; Zhou D
Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Shear NH; Spielberg SP
J Clin Invest; 1988 Dec; 82(6):1826-32. PubMed ID: 3198757
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant drug hypersensitivity.
Galindo PA; Borja J; Gómez E; Mur P; Gudín M; García R; Encinas C; Romero G; Garrido JA; Cortina P; Feo F
J Investig Allergol Clin Immunol; 2002; 12(4):299-304. PubMed ID: 12926190
[TBL] [Abstract][Full Text] [Related]
10. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
11. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R
Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983
[TBL] [Abstract][Full Text] [Related]
12. Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance.
Okada Y; Seo T; Ishitsu T; Wanibuchi A; Hashimoto N; Higa Y; Nakagawa K
Ther Drug Monit; 2008 Aug; 30(4):540-3. PubMed ID: 18641551
[TBL] [Abstract][Full Text] [Related]
13. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
Ozeki T; Mushiroda T; Yowang A; Takahashi A; Kubo M; Shirakata Y; Ikezawa Z; Iijima M; Shiohara T; Hashimoto K; Kamatani N; Nakamura Y
Hum Mol Genet; 2011 Mar; 20(5):1034-41. PubMed ID: 21149285
[TBL] [Abstract][Full Text] [Related]
16. Cross Hypersensitivity Syndrome between Phenytoin and Carbamazepine.
Sierra NM; García B; Marco J; Plaza S; Hidalgo F; Bermejo T
Pharm World Sci; 2005 Jun; 27(3):170-4. PubMed ID: 16096883
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: two cases.
Hu FY; Wu XT; An DM; Yan B; Stefan H; Zhou D
Seizure; 2011 Jun; 20(5):431-2. PubMed ID: 21334226
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant and neurotoxic effects of intracerebroventricular injection of phenytoin, phenobarbital and carbamazepine in an amygdala-kindling model of epilepsy in the rat.
Barcia JA; Rubio P; Alós M; Serralta A; Belda V
Epilepsy Res; 1999 Feb; 33(2-3):159-67. PubMed ID: 10094427
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic drug hypersensitivity syndrome.
Schlienger RG; Shear NH
Epilepsia; 1998; 39 Suppl 7():S3-7. PubMed ID: 9798755
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant hypersensitivity syndrome.
Vittorio CC; Muglia JJ
Arch Intern Med; 1995 Nov; 155(21):2285-90. PubMed ID: 7487252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
